Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DISCOVERY PARTNERS INTERNATIONAL INC | 85,000 | reported | 14 Jan 2015 | tx 1+85,000 |
| Syros Pharmaceuticals, Inc. | 0 | reported | 18 Nov 2024 | tx 33+1,101,083−143,418 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Nov 2024 | SALE | Syros Pharmaceuticals, Inc. | 12,099 | 0.20 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | — | |
| 31 Oct 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6,776 | 2.09 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | 0.00 USD | deriv |
| 03 Apr 2024 | SALE | Syros Pharmaceuticals, Inc. | 10,451 | 4.95 USD | |
| 01 Apr 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 4,732 | 5.12 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13,333 | — | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 02 Apr 2024 | SALE | Syros Pharmaceuticals, Inc. | 150 | 4.98 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13,333 | 0.00 USD | deriv |
| 12 Dec 2023 | SALE | Syros Pharmaceuticals, Inc. | 6,287 | 4.95 USD | |
| 06 Dec 2023 | SALE | Syros Pharmaceuticals, Inc. | 6,287 | 3.95 USD | |
| 01 Nov 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6,301 | 2.22 USD | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | — | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | 0.00 USD | deriv |
| 31 Jul 2023 | SALE | Syros Pharmaceuticals, Inc. | 7,348 | 3.95 USD | |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 03 Apr 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 623 | 2.58 USD | |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 06 Oct 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 49,750 | 0.00 USD | deriv |
| 06 Oct 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 37,750 | 0.00 USD | deriv |
| 01 Apr 2022 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 27,281 | 1.12 USD | |
| 15 Feb 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 125,000 | 0.00 USD | deriv |